These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21530741)

  • 21. Dysregulation of intestinal mucosal immunity: implications in inflammatory bowel disease.
    Laroux FS; Pavlick KP; Wolf RE; Grisham MB
    News Physiol Sci; 2001 Dec; 16():272-7. PubMed ID: 11719604
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypoxia, the HIF pathway and neutrophilic inflammatory responses.
    Thompson AA; Binham J; Plant T; Whyte MK; Walmsley SR
    Biol Chem; 2013 Apr; 394(4):471-7. PubMed ID: 23324383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory process.
    Ortiz-Masià D; Díez I; Calatayud S; Hernández C; Cosín-Roger J; Hinojosa J; Esplugues JV; Barrachina MD
    PLoS One; 2012; 7(10):e48535. PubMed ID: 23119050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.
    Colgan SP; Eltzschig HK
    Annu Rev Physiol; 2012; 74():153-75. PubMed ID: 21942704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1.
    To KK; Huang LE
    J Biol Chem; 2005 Nov; 280(45):38102-7. PubMed ID: 16157596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.
    Kasiganesan H; Sridharan V; Wright G
    Acta Physiol (Oxf); 2007 Jun; 190(2):163-9. PubMed ID: 17394573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosis.
    Steiner CA; Cartwright IM; Taylor CT; Colgan SP
    Am J Physiol Cell Physiol; 2022 Sep; 323(3):C866-C878. PubMed ID: 35912990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-inducible factor 1 (HIF-1) pathway.
    Semenza GL
    Sci STKE; 2007 Oct; 2007(407):cm8. PubMed ID: 17925579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress.
    Siddiq A; Aminova LR; Ratan RR
    Neurochem Res; 2007; 32(4-5):931-46. PubMed ID: 17342411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia in the Pathophysiology of Inflammatory Bowel Disease.
    Morales M; Xue X
    Compr Physiol; 2023 Jun; 13(3):4767-4783. PubMed ID: 37358514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase.
    Jeon H; Kim H; Choi D; Kim D; Park SY; Kim YJ; Kim YM; Jung Y
    Mol Pharmacol; 2007 Jun; 71(6):1676-84. PubMed ID: 17377063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}-dependent mechanisms.
    Schultz K; Murthy V; Tatro JB; Beasley D
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L921-7. PubMed ID: 19304911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].
    Stolze IP; Tian YM; Appelhoff RJ; Turley H; Wykoff CC; Gleadle JM; Ratcliffe PJ
    J Biol Chem; 2004 Oct; 279(41):42719-25. PubMed ID: 15302861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF).
    Ozer A; Wu LC; Bruick RK
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7481-6. PubMed ID: 15897452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiologic hypoxia in the intestinal mucosa: a central role for short-chain fatty acids.
    Wang T; Wang RX; Colgan SP
    Am J Physiol Cell Physiol; 2024 Oct; 327(4):C1087-C1093. PubMed ID: 39159391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD.
    Van Welden S; Selfridge AC; Hindryckx P
    Nat Rev Gastroenterol Hepatol; 2017 Oct; 14(10):596-611. PubMed ID: 28853446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A yeast three-hybrid system that reconstitutes mammalian hypoxia inducible factor regulatory machinery.
    Alcaide-German ML; Vara-Vega A; Garcia-Fernandez LF; Landazuri MO; del Peso L
    BMC Cell Biol; 2008 Apr; 9():18. PubMed ID: 18402654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue metabolism and host-microbial interactions in the intestinal mucosa.
    Chun C; Zheng L; Colgan SP
    Free Radic Biol Med; 2017 Apr; 105():86-92. PubMed ID: 27687211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal inflammation downregulates PHD1 expression promoting a barrier-protective HIF-1α response in ulcerative colitis patients.
    Brown E; Rowan C; Strowitzki MJ; Fagundes RR; Faber KN; Güntsch A; Halligan DN; Kugler J; Jones F; Lee CT; Doherty G; Taylor CT
    FASEB J; 2020 Mar; 34(3):3732-3742. PubMed ID: 31944416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
    Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
    Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.